Making prescription drugs more affordable was a key goal of the Inflation Reduction Act (IRA). However, most Medicare ...

A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for ...

Launch prices for anticancer drugs covered under Medicare Part D continue to rise, even with recent Inflation Reduction Act cost control measures.

Medicare Trustees' Report: The Medicare Trustees annual report provides projections for Medicare program costs. For 2026, ...

Without a fix to Medicare underpaying physicians, the result will be doctor shortages, declining healthcare quality, and ...

Increasingly, the drumbeat of financial advisers who say $1 million won’t be enough for retirement is growing louder. On ...

IRA’s $2,000 out-of-pocket cap helps few; most won’t hit the threshold Insurers raise deductibles, replace flat co-pays with ...

Tech advancements have made it possible to continuously monitor and rebalance portfolios, allowing for harvesting losses ...

Chairman James Comer seeks briefing on Medicare Part D redesign's impact, fearing it may raise drug costs and limit access.

Even though a significant number of libertarians supported Trump for president, he clearly has shown no respect for ...